New Hair Loss Drug Approved: Restores 80% of Hair Loss In Some Alopecia Patients

Indonesia Berita Berita

New Hair Loss Drug Approved: Restores 80% of Hair Loss In Some Alopecia Patients
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 ScienceAlert
  • ⏱ Reading Time:
  • 56 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 68%

Severe hair loss from the autoimmune condition, alopecia areata, could be reversible in some patients if they take a daily oral drug for several months.

, could be reversible in some patients if they take a daily oral drug for several months.

A recent randomized, double-blind clinical trial on the medication has shown such promising results, the United States Food and Drug Administration Alopecia is marked by hair loss on the scalp, face, or body. It occurs when the immune system begins attacking a person's own hair follicles, and while most patients are otherwise healthy, patchy or complete losses of hair can have serious mental and emotional impacts.

Some patients with severe forms of the disease lose all of their scalp hair, eyelashes, eyebrows, and all the rest of their body hair as well, a condition known as. Such severe cases tend to be especially resistant to available treatments, but a new drug called ritlecitinib could help change that. In stage two and three clinical trials, the oral medicine reversed up to 80 percent of hair loss on the scalp for close to a quarter of all patients, and so far appears to be

one of the only treatments for severe alopecia that is both effective and well-tolerated by a significant number of people. Its approval also makes it the only treatment available for children.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

ScienceAlert /  🏆 63. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Experimental drug could offer more weight loss than any drug now on the market, study findsThe experimental drug, retatrutide, helped people lose, on average, about 24% of their body weight, the equivalent of about 58 pounds, in a mid-stage clinical trial, the company says.
Baca lebih lajut »

Pfizer scraps one weight loss drug in race to develop Ozempic rivalPfizer Inc said on Monday it will drop the development of experimental obesity and diabetes drug lotiglipron and focus on another treatment, as the drugmaker races to tap the promising market for weight loss drugs.
Baca lebih lajut »

The 24 Best Hair Masks for the Softest Hair of Your LifeYour dry, damaged, or dull hair deserves a treat.
Baca lebih lajut »

Teens with severe obesity are turning to surgery and new weight loss drugsA small but growing group of young teens are turning to drastic treatments to lose large amounts of weight, things like body-altering surgery and new drugs that rewire metabolism.
Baca lebih lajut »

New pill forms of Ozempic, Wegovy a diabetes and weight-loss ‘game-changer’If approved, the new pill forms of semaglutide could revolutionize the fast-changing weight-loss landscape.
Baca lebih lajut »



Render Time: 2025-02-27 12:38:07